Obstetrics & Gynecology · Pleasanton, CA
NPI
1801974985
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7601 Stoneridge Dr
Pleasanton, CA, 94588
Phone (925) 847-5000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$182K
881 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gul I Qidwai prescribed most often to Medicare patients was Yuvafem (Estradiol), with 281 prescriptions and refills. In total Gul I Qidwai wrote 881 Medicare prescriptions that cost $182K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Yuvafem Estradiol | 281 | 776 | 104 | $31K |
| Cephalexin Generic | 90 | 120 | 63 | $700 |
| Estradiol Generic | 77 | 337 | 52 | $3,534 |
| Estring Estradiol | 66 | 198 | 20 | $40K |
| Myrbetriq Mirabegron | 63 | 155 | 27 | $73K |
| Trospium Chloride Generic | 54 | 172 | 20 | $2,435 |
| Oxycodone Hcl Generic | 46 | 46 | 44 | $338 |
| Ibuprofen Generic | 30 | 30 | 27 | $307 |
| Mirabegron Er Mirabegron | 29 | 72 | 23 | $16K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 17 | 17 | 16 | $170 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 17 | 26 | 13 | $198 |
| Cefadroxil Generic | 16 | 16 | 14 | $208 |
| Methenamine Hippurate Generic | 15 | 38 | Under 11 | $947 |
| Solifenacin Succinate Generic | 15 | 46 | Under 11 | $396 |
| Trospium Chloride Er Trospium Chloride | 14 | 41 | Under 11 | $1,430 |
Brand drugs: 135 claims; generic drugs: 746 claims; opioid claims: 47.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gul I Qidwai were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.